ATE452900T1 - Impfstoff gegen das west-nile-virus - Google Patents
Impfstoff gegen das west-nile-virusInfo
- Publication number
- ATE452900T1 ATE452900T1 AT03783570T AT03783570T ATE452900T1 AT E452900 T1 ATE452900 T1 AT E452900T1 AT 03783570 T AT03783570 T AT 03783570T AT 03783570 T AT03783570 T AT 03783570T AT E452900 T1 ATE452900 T1 AT E452900T1
- Authority
- AT
- Austria
- Prior art keywords
- west nile
- nile virus
- vaccine against
- vaccines
- methods
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000710886 West Nile virus Species 0.000 title abstract 2
- 241000710831 Flavivirus Species 0.000 abstract 1
- 206010057293 West Nile viral infection Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42659202P | 2002-11-15 | 2002-11-15 | |
| PCT/US2003/036623 WO2004045529A2 (en) | 2002-11-15 | 2003-11-13 | West nile virus vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE452900T1 true ATE452900T1 (de) | 2010-01-15 |
Family
ID=32326380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03783570T ATE452900T1 (de) | 2002-11-15 | 2003-11-13 | Impfstoff gegen das west-nile-virus |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7507415B2 (de) |
| EP (1) | EP1575979B1 (de) |
| JP (1) | JP4683926B2 (de) |
| KR (1) | KR101150584B1 (de) |
| AT (1) | ATE452900T1 (de) |
| AU (1) | AU2003290985B2 (de) |
| BR (1) | BRPI0316346B1 (de) |
| CA (1) | CA2505942C (de) |
| DE (1) | DE60330708D1 (de) |
| ES (1) | ES2337893T3 (de) |
| IL (2) | IL168584A (de) |
| MX (1) | MXPA05005140A (de) |
| RU (1) | RU2376374C2 (de) |
| WO (1) | WO2004045529A2 (de) |
| ZA (1) | ZA200503871B (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6962708B1 (en) * | 1997-02-28 | 2005-11-08 | Acambis, Inc. | Chimeric flavivirus vaccines |
| PL371187A1 (en) | 2001-06-01 | 2005-06-13 | Acambis, Inc. | Chimeric flavivirus vectors |
| US20050002968A1 (en) * | 2002-01-15 | 2005-01-06 | Monath Thomas P. | Flavivirus vaccines |
| JP2005519639A (ja) | 2002-01-15 | 2005-07-07 | アカンビス インコーポレーティッド | フラビウイルスワクチン |
| AU2003239932A1 (en) * | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| WO2004016586A2 (en) * | 2002-08-16 | 2004-02-26 | Board Of Regents The University Of Texas System | Compositions and methods related to flavivirus envelope protein domain iii antigens |
| AU2003290985B2 (en) | 2002-11-15 | 2010-04-01 | Acambis Inc. | West nile virus vaccine |
| WO2006029300A2 (en) | 2004-09-09 | 2006-03-16 | Research Development Foundation | Flavivirus variants having phenotypic variation and immunogenic compositions thereof |
| WO2006044857A2 (en) * | 2004-10-20 | 2006-04-27 | Acambis Inc. | Vaccines against japanese encephalitis virus and west nile virus |
| AU2005320001B2 (en) | 2004-12-24 | 2011-05-19 | The Research Foundation For Microbial Diseases Of Osaka University | Attenuated chimeric flavivirus bearing attenuated Japanese encephalitis virus gene as backbone |
| AU2013204985B2 (en) * | 2005-04-24 | 2016-01-28 | Sanofi Pasteur Biologics, Llc | Recombinant flavivirus vaccines |
| CN103031279B (zh) * | 2005-04-24 | 2015-11-18 | 赛诺菲巴斯德生物制药有限责任公司 | 重组黄病毒疫苗 |
| US8017754B2 (en) * | 2005-07-22 | 2011-09-13 | Research Development Foundation | Attenuated virus strains and uses thereof |
| CA2668834C (en) | 2006-11-07 | 2016-10-11 | Sanofi Pasteur Biologics Co. | Stabilization of vaccines by lyophilization |
| EP2099916A2 (de) * | 2006-12-22 | 2009-09-16 | Dow AgroSciences LLC | Aus pflanzen hergestellte west-nil-virus-impfstoffe, vektoren und pflanzencodonoptimierte sequenzen |
| ES2615390T3 (es) | 2008-03-05 | 2017-06-06 | Sanofi Pasteur | Proceso para estabilizar una composición de vacuna que contiene adyuvante |
| EP2143440A1 (de) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Stabilisierungssubstanz und Impfzusammensetzung, die ein oder mehrere abgeschwächte lebende Flaviviridae enthält |
| AU2009287449B2 (en) | 2008-08-29 | 2015-04-30 | Boehringer Ingelheim Animal Health USA Inc. | West nile virus vaccine |
| WO2010085358A2 (en) * | 2009-01-23 | 2010-07-29 | The Board Of Regents Of The University Of Texas System | Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof |
| WO2011026139A1 (en) * | 2009-08-31 | 2011-03-03 | Gen-Probe Incorporated | Dengue virus assay |
| BR112012024224A2 (pt) * | 2010-03-24 | 2016-11-29 | Arbovax Inc | mutações da faixa de hospedeiro de flavivírus e seu uso. |
| WO2012003320A2 (en) | 2010-07-01 | 2012-01-05 | Research Development Foundation | Flavivirus host-range mutations and uses thereof |
| BR112013023354B1 (pt) | 2011-03-14 | 2022-02-15 | Boehringer Ingelheim Animal Health Usa Inc | Composição imunogênica compreendendo cepas de vírus da rinite equina a (erav) e seu método de produção |
| WO2013138670A1 (en) * | 2012-03-15 | 2013-09-19 | Icahn School Of Medicine At Mount Sinai | Yellow fever virus ns5 mutants as flavivirus vaccine candidates |
| US9267114B2 (en) * | 2012-11-07 | 2016-02-23 | Southern Research Institute | Flavivirus envelope protein mutations affecting virion disassembly |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184024B1 (en) * | 1988-07-14 | 2001-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and/or growth-restricted flaviviruses |
| DE69230316T2 (de) | 1991-09-19 | 2000-07-13 | Us Health | Chimäre und/oder wachstumsgehemmte flaviviren |
| US6136561A (en) * | 1995-05-24 | 2000-10-24 | Hawaii Biotechnology Group, Inc. | Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems |
| US6962708B1 (en) * | 1997-02-28 | 2005-11-08 | Acambis, Inc. | Chimeric flavivirus vaccines |
| CA2282790C (en) * | 1997-02-28 | 2011-04-19 | St. Louis University | Chimeric flavivirus vaccines |
| BRPI9701774B8 (pt) * | 1997-04-11 | 2015-09-29 | Fundação Oswaldo Cruz Fiocruz | cdna mutante e infeccioso do vírus da febre amarela, constructo de dna, vírus recombinante de febre amarela e vacina para humanos contra infecções de febre amarela. |
| US6416763B1 (en) * | 1998-08-28 | 2002-07-09 | Hawaii Biotechnology Group, Inc. | Recombinant nonstructural protein subunit vaccine against flaviviral infection |
| AU1813901A (en) | 1999-12-01 | 2001-06-12 | Oravax, Inc | Chimeric flavivirus vaccines |
| GB2372991B (en) * | 2001-03-09 | 2004-11-17 | Fiocruz Fundacao Oswaldo Cruz | Flavivirus expression vector |
| PL371187A1 (en) | 2001-06-01 | 2005-06-13 | Acambis, Inc. | Chimeric flavivirus vectors |
| US6682883B1 (en) * | 2001-07-19 | 2004-01-27 | Acambis, Inc. | Diagnosis of flavivirus infection |
| DK1441761T3 (da) | 2001-10-19 | 2007-08-27 | Acambis Inc | Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr |
| DE20120256U1 (de) * | 2001-12-14 | 2002-03-07 | Häfele GmbH & Co., 72202 Nagold | Beschlag |
| JP2005519639A (ja) | 2002-01-15 | 2005-07-07 | アカンビス インコーポレーティッド | フラビウイルスワクチン |
| US20050002968A1 (en) | 2002-01-15 | 2005-01-06 | Monath Thomas P. | Flavivirus vaccines |
| AU2003239932A1 (en) | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| AU2003290985B2 (en) | 2002-11-15 | 2010-04-01 | Acambis Inc. | West nile virus vaccine |
| US7189403B2 (en) * | 2003-06-30 | 2007-03-13 | Institut Pasteur | Attenuated flavivirus strains containing a mutated M-ectodomain and their applications |
| WO2005040390A1 (en) | 2003-07-21 | 2005-05-06 | Shanghai Tengen Biomedical Co., Ltd. | A recombinant vaccine using yellow fever virus as vector |
| WO2005049815A1 (en) | 2003-11-21 | 2005-06-02 | K.U.Leuven Research & Development | Flavivirus replication |
| WO2006044857A2 (en) | 2004-10-20 | 2006-04-27 | Acambis Inc. | Vaccines against japanese encephalitis virus and west nile virus |
| CN103031279B (zh) | 2005-04-24 | 2015-11-18 | 赛诺菲巴斯德生物制药有限责任公司 | 重组黄病毒疫苗 |
| BRPI0504945B8 (pt) | 2005-10-31 | 2022-08-02 | Fundacao Oswaldo Cruz | Método para a produção de flavivirus recombinante contendo sequências de nucleotídeos codificantes de uma proteína heteróloga, constructo de dna, flavivirus, e, composição vacinal para imunizar contra flavivirus e/ou outros patógenos. |
-
2003
- 2003-11-13 AU AU2003290985A patent/AU2003290985B2/en not_active Ceased
- 2003-11-13 JP JP2004553787A patent/JP4683926B2/ja not_active Expired - Fee Related
- 2003-11-13 RU RU2005118419/13A patent/RU2376374C2/ru not_active IP Right Cessation
- 2003-11-13 WO PCT/US2003/036623 patent/WO2004045529A2/en not_active Ceased
- 2003-11-13 BR BRPI0316346A patent/BRPI0316346B1/pt not_active IP Right Cessation
- 2003-11-13 MX MXPA05005140A patent/MXPA05005140A/es active IP Right Grant
- 2003-11-13 AT AT03783570T patent/ATE452900T1/de not_active IP Right Cessation
- 2003-11-13 DE DE60330708T patent/DE60330708D1/de not_active Expired - Lifetime
- 2003-11-13 ES ES03783570T patent/ES2337893T3/es not_active Expired - Lifetime
- 2003-11-13 CA CA2505942A patent/CA2505942C/en not_active Expired - Fee Related
- 2003-11-13 KR KR1020057008744A patent/KR101150584B1/ko not_active Expired - Fee Related
- 2003-11-13 EP EP03783570A patent/EP1575979B1/de not_active Expired - Lifetime
- 2003-11-17 US US10/715,868 patent/US7507415B2/en not_active Expired - Fee Related
-
2005
- 2005-05-13 ZA ZA200503871A patent/ZA200503871B/en unknown
- 2005-05-15 IL IL168584A patent/IL168584A/en active IP Right Grant
-
2009
- 2009-03-23 US US12/409,120 patent/US8088391B2/en not_active Expired - Fee Related
- 2009-12-27 IL IL202978A patent/IL202978A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004045529A3 (en) | 2004-08-26 |
| IL168584A (en) | 2010-12-30 |
| ES2337893T3 (es) | 2010-04-30 |
| AU2003290985A1 (en) | 2004-06-15 |
| KR101150584B1 (ko) | 2012-06-27 |
| CA2505942C (en) | 2012-03-13 |
| US20100086564A1 (en) | 2010-04-08 |
| IL202978A (en) | 2013-11-28 |
| JP2006506092A (ja) | 2006-02-23 |
| EP1575979A4 (de) | 2006-06-21 |
| ZA200503871B (en) | 2006-08-30 |
| IL202978A0 (en) | 2011-08-01 |
| HK1083192A1 (en) | 2006-06-30 |
| US20070275015A9 (en) | 2007-11-29 |
| US8088391B2 (en) | 2012-01-03 |
| JP4683926B2 (ja) | 2011-05-18 |
| RU2376374C2 (ru) | 2009-12-20 |
| DE60330708D1 (de) | 2010-02-04 |
| RU2005118419A (ru) | 2006-01-20 |
| US7507415B2 (en) | 2009-03-24 |
| EP1575979A2 (de) | 2005-09-21 |
| CA2505942A1 (en) | 2004-06-03 |
| BR0316346A (pt) | 2005-09-27 |
| US20050053624A1 (en) | 2005-03-10 |
| BRPI0316346B1 (pt) | 2016-05-31 |
| EP1575979B1 (de) | 2009-12-23 |
| MXPA05005140A (es) | 2005-08-19 |
| AU2003290985B2 (en) | 2010-04-01 |
| WO2004045529A2 (en) | 2004-06-03 |
| KR20050072143A (ko) | 2005-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60330708D1 (de) | Impfstoff gegen das west-nile-virus | |
| WO2003101397A3 (en) | Tetravalent dengue vaccines | |
| NO20070988L (no) | Vaksine for forebygging og behandling av HIV-infeksjon | |
| ATE451119T1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
| ATE426412T1 (de) | Adjuvante influenza-vakzine | |
| NO20061911L (no) | Immunogene sammensetninger | |
| HUP0301180A2 (hu) | Imidazokinolinaminok adjuvánsként való használata DNS vakcinálásban | |
| NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
| MY148075A (en) | Vaccines against japanese encephalitis virus and west nile virus | |
| EP1545599A4 (de) | Immunogene zusammensetzungen und ihre diagnostische und therapeutische verwendung | |
| EP1307130A4 (de) | Impfstoff gegen menschlichen immunschwächevirus | |
| CY2016018I1 (el) | Εμβολιο κατα του ιου του δυτικου νειλου | |
| UY27798A1 (es) | Inhibidores de la arn polimerasa dependiente de arn del virus de la hepatits c y composiciones y tratamientos que los usan. | |
| ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
| WO2007002470A3 (en) | Inactivated chimeric vaccines and related methods of use | |
| NO20052136L (no) | Vaksine mot Hepatitt C-virus (HCV). | |
| ATE507286T1 (de) | Immunisierung von fischen gegen virusinfektion | |
| DK1520587T3 (da) | Allergivaccinesammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf til allergibehandling | |
| DK2206514T3 (da) | Rekombinante intracellulære patogene immunogene sammensætninger og metoder til anvendelse | |
| MY192543A (en) | Dengue virus vaccine compositions and methods of use thereof | |
| EA200301151A1 (ru) | Вакцина против натуральной оспы | |
| ATE380557T1 (de) | E. coli vakzin zur protektion von geflügel gegen colibazillose | |
| ATE401392T1 (de) | Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion | |
| DK1159426T3 (da) | Kloning og udtryk af Haemophilus somnus transferrin-bindende proteiner | |
| AU2003253894A8 (en) | Combination therapies with ftc for the treatment of hepatitis b virus infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |